Taro to Release Full Year Results on May 20, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024.

The release will be accessible on Taro’s website at www.taro.com.

About Taro 
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240515172110/en/

William J. Coote
VP, Chief Financial Officer
(914) 345-9001
[email protected]

Source: Taro Pharmaceutical Industries Ltd.

You May Also Be Interested In

• Stewart Expands Commercial Energy & Infrastructure Capabilities with Acquisition of Tower Title
• GitLab’s second-quarter revenue jumps 21% as AI demand drives bookings
• Tactical Resources to Ring the Nasdaq Closing Bell